According to a market report by Lucintel, the future of the global scopolamine hydrobromide market looks promising with opportunities in the hospital and clinic markets. The global scopolamine hydrobromide market is expected to grow with a CAGR of 4.1% from 2025 to 2031. The major drivers for this market are the increasing prevalence of motion sickness disorders, the rising demand for postoperative nausea treatments, and the growing use in pharmaceutical injectable formulations.
A more
than 150-page report to understand trends, opportunity and forecast in global scopolamine
hydrobromide market to 2031 by type (injections, oral, and topical),
application (hospital and clinic), and region (North America, Europe, Asia
Pacific, and the Rest of the World).
Lucintel
forecasts that, within the type category, injection is expected to witness the
highest growth over the forecast period.
Within the
application category, hospital is expected to witness higher growth.
Download
sample by clicking on scopolamine
hydrobromide market.
In terms
of region, APAC is expected to witness the highest growth over the forecast
period.
Novartis,
Mylan, Teva Pharmaceuticals, Baxter International, Sandoz, Amgen, Accord
Healthcare, Manus Aktteva Biopharma, ALKALOIDS CORPORATION, Sigma-Aldrich are the major suppliers in the scopolamine hydrobromide market.
This unique research
report will enable you to make confident business decisions in this globally
competitive marketplace. For a detailed table of contents, contact Lucintel at
+1-972-636-5056 or write us at helpdesk@lucintel.com. To get access of more than 1000 reports at fraction of cost
visit Lucintel's Analytics
Dashboard.
About Lucintel
At Lucintel, we offer solutions for
you growth through game changer ideas and robust market &
unmet needs analysis. We are based in
Dallas, TX and have been a trusted advisor for 1,000+ clients for over 20 years.
We are quoted in several publications like the Wall Street Journal, ZACKS, and
the Financial Times.
Contact:
Roy Almaguer
Lucintel
Dallas, Texas, USA
Email: roy.almaguer@lucintel.com
Tel. +1-972-636-5056
Explore Our Latest Publications
Hidradenitis Suppurativa Treatment Market
LiDAR Perimeter Detection Market
No comments:
Post a Comment